Document is current
Any future updates will be listed below
-
Authors
Murphy, Daniel A. J.
Xie, Jiaxin
Harmer, Catherine J.
Browning, Michael
Pulcu, Erdem https://orcid.org/0000-0002-2170-0677
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 25 March 2022
First Online: 14 April 2022
Competing interests
: E.P. has received consultancy fees from Janssen Pharmaceuticals. M.B. has received travel expenses from Lundbeck for attending conferences and acted as a consultant for Jansen Research and CHDR. C.J.H. has received consultancy fees from p1vital. Lundbeck, Pfizer, Sage Pharmaceuticals, Servier, Zogenixs and J&J. D.A.J.M. and J.X. do not have any competing interests.
